Cogent Biosciences (COGT) – Analyst PT Change
-
Jefferies Assumes Cogent (COGT) at Buy, 'A Validated Tool "KIT" for Mast Cell Diseases & GI Cancer'
-
Cogent (COGT) PT Raised to $19 at H.C. Wainwright
-
-
-
-
-
-
-
-
-
-
-
Back to COGT Stock Lookup